Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med Chin    2009, Vol. 3 Issue (2) : 136-140     DOI: 10.1007/s11684-009-0029-2
Effects of resistin on insulin signaling in endothelial cells
Zhizhen LI1, Fangping LI2, Jianhong YE2, Li YAN2, Zuzhi FU2()
1. Department of Endocrinology, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China; 2. Department of Endocrinology, Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China
Download: PDF(114 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

The objective of this study was to investigate the effects of resistin on insulin signaling in human umbilical vein endothelial cells (HUVECs). HUVECs were incubated with recombinant human resistin (0-100 ng/mL) for 24 h. Akt and endothelial nitric oxide synthase (eNOS) phosphorylation levels of endothelial cells under basal or insulin stimulated conditions were measured by Western blot. Nitric oxide (NO) production of HUVECs was also detected. The results showed that resistin could significantly inhibit Akt and eNOS phosphorylation and NO production in endothelial cells under insulin stimulated conditions (P< 0.05 vs control). But under basal conditions, treatment with resistin could result in a decrease in eNOS phosphorylation (P< 0.05 vs control) but had no effect on NO production and Akt phosphorylation levels. These findings suggested that resistin exerted an inhibitory effect on NO production by inhibiting insulin signaling and eNOS phosphorylation in endothelial cells.

Keywords resistin      endothelium      nitric oxide      endothelial nitric oxide synthase      Akt-binding protein, mouse     
Corresponding Authors: FU Zuzhi,   
Issue Date: 05 June 2009
URL:     OR
groupscontrol cells15 ng/mL resistin50 ng/mL resistin100 ng/mL resistin
without insulin5.97 ± 1.655.47 ± 0.365.45 ± 1.955.71 ± 0.67
insulin stimulated4.89 ± 0.584.01 ± 0.69*3.76 ± 0.71*3.73 ± 0.45*
Tab.1  NO production levels of each group
Fig.1  Akt phosphorylation level in human umbilical vein endothelial cells without insulin stimulation: a representative Western blot of Akt phosphorylation. 1: control group; 2: res15 group; 3: res50 group; 4: res100 group.
Fig.2  Insulin stimulated Akt phosphorylation level in human umbilical vein endothelial cells: a representative Western blot of Akt phosphorylation. 1: control group; 2: res15 group; 3: res50 group; 4: res100 group.
Fig.3  eNOS phosphorylation level in human umbilical vein endothelial cells without insulin stimulation: a representative Western blot of eNOS phosphorylation. 1: control group; 2: res15 group; 3: res50 group; 4: res100 group.
Fig.4  Insulin stimulated eNOS phosphorylation level in human umbilical vein endothelial cells: a representative Western blot of eNOS phosphorylation. 1: control group; 2: res15 group; 3: res50 group; 4: res100 group.
without insulininsulin stimulatedwithout insulininsulin stimulated
control cells0.67 ± 0.161.14 ± 0.221.48 ± 0.130.17 ± 0.02
15 ng/mL resistin0.61 ± 0.130.79 ± 0.19*1.02 ± 0.110.12 ± 0.03*
50 ng/mL resistin0.53 ± 0.150.68 ± 0.10*1.01 ± 0.090.13 ± 0.34*
100 ng/mL resistin0.49 ± 0.160.60 ± 0.07*0.92 ± 0.130.13 ± 0.03*
Tab.2  Akt and eNOS phosphorylation levels of each group
1 Grundy S M, Brewer H B Jr, Cleeman J I, Smith S C Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation , 2004, 109(3): 433-438
doi: 10.1161/01.CIR.0000111245.75752.C6
2 Begum N. Insulin signaling in the vasculature. Front Biosci , 2003, 8: s796-s804
doi: 10.2741/1146
3 Wellen K E, Hotamisligil G S. Inflammation, stress, and diabetes. J Clin Invest , 2005, 115(5): 1111-1119
4 Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature , 2001, 409(6818): 307-312
doi: 10.1038/35053000
5 Steppan C M, Brown E J, Wright C M, Bhat S, Banerjee R R, Dai C Y, Enders G H, Silberg D G, Wen X, Wu G D, Lazar M A. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A , 2001, 98(2): 502-506
doi: 10.1073/pnas.98.2.502
6 Patel L, Buckels A C, Kinghorn I J, Murdock P R, Holbrook J D, Plumpton C, Macphee C H, Smith S A. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun , 2003, 300(2): 472-476
doi: 10.1016/S0006-291X(02)02841-3
7 Kaser S, Kaser A, Sandhofer A, Ebenbichler C F, Tilg H, Patsch J R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun , 2003, 309(2): 286-290
doi: 10.1016/j.bbrc.2003.07.003
8 Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol , 2005, 174(9): 5789-5795
9 Minter A J, Dawes J, Chesterman C N. Effects of heparin and endothelial cell growth supplement on haemostatic functions of vascular endothelium. Thromb Haemost , 1992, 67(6): 718-723
10 Hingorani A D, Cross J, Kharbanda R K, Mullen M J, Bhagat K, Taylor M, Donald A E, Palacios M, Griffin G E, Deanfield J E, MacAllister R J, Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation , 2000, 102(9): 994-999
11 Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation , 1997, 96(9): 3042-3047
12 Reilly M P, Lehrke M, Wolfe M L, Rohatgi A, Lazar M A, Rader D J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation , 2005, 111(7): 932-939
doi: 10.1161/01.CIR.0000155620.10387.43
13 Shen Y H, Zhang L, Gan Y, Wang X, Wang J, LeMaire S A, Coselli J S, Wang X L. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells. J Biol Chem , 2006, 281(12): 7727-7736
doi: 10.1074/jbc.M511105200
14 Verma S, Li S H, Wang C H, Fedak P W, Li R K, Weisel R D, Mickle D A. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation , 2003, 108(6): 736-740
doi: 10.1161/01.CIR.0000084503.91330.49
15 Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun , 2004, 314(2): 415-419
doi: 10.1016/j.bbrc.2003.12.104
16 Calabro P, Samudio I, Willerson J T, Yeh E T. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation , 2004, 110(21): 3335-3340
doi: 10.1161/01.CIR.0000147825.97879.E7
17 Graveleau C, Zaha V G, Mohajer A, Banerjee R R, Dudley-Rucker N, Steppan C M, Rajala M W, Scherer P E, Ahima R S, Lazar M A, Abel E D. Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action. J Biol Chem , 2005, 280(36): 31679-31685
doi: 10.1074/jbc.M504008200
18 Patel S D, Rajala M W, Rossetti L, Scherer P E, Shapiro L. Disulfide-dependent multimeric assembly of resistin family hormones. Science , 2004, 304(5674): 1154-1158
doi: 10.1126/science.1093466
19 Wyatt A W, Steinert J R, Wheeler-Jones C P, Morgan A J, Sugden D, Pearson J D, Sobrevia L, Mann G E. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J , 2002, 16(12): 1584-1594
doi: 10.1096/fj.01-0125com
20 Morrow V A, Foufelle F, Connell J M, Petrie J R, Gould G W, Salt I P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem , 2003, 278(34): 31629-31639
doi: 10.1074/jbc.M212831200
21 Satoh H, Nguyen M T, Miles P D, Imamura T, Usui I, Olefsky J M. Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats. J Clin Invest , 2004, 114(2): 224-231
22 Kitagawa Y, Bujo H, Takahashi K, Shibasaki M, Ishikawa K, Yagui K, Hashimoto N, Noda K, Nakamura T, Yano S, Saito Y. Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia , 2004, 47(10): 1847-1853
doi: 10.1007/s00125-004-1530-4
23 Rangwala S M, Rich A S, Rhoades B, Shapiro J S, Obici S, Rossetti L, Lazar M A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes , 2004, 53(8): 1937-1941
doi: 10.2337/diabetes.53.8.1937
24 Moon B, Kwan J J, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab , 2003, 285(1): E106-E115
25 Muse E D, Obici S, Bhanot S, Monia B P, McKay R A, Rajala M W, Scherer P E, Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest , 2004, 114(2): 232-239
26 Fehmann H C, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res , 2002, 34(11,12): 671-673
27 Burnett M S, Lee C W, Kinnaird T D, Stabile E, Durrani S, Dullum M K, Devaney J M, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo L C, Jang G J, Andrews J A, Zhu J, Epstein S E. The potential role of resistin in atherogenesis. Atherosclerosis , 2005, 182(2): 241-248
doi: 10.1016/j.atherosclerosis.2005.02.014
[1] Fang-Ping LI, Zhi-Zhen LI, Miao ZHANG, Li YAN, Zu-Zhi FU. Effects of resistin on skeletal glucose metabolism[J]. Front Med Chin, 2010, 4(3): 329-335.
[2] Qigong LIU M D , Yan ZENG , Jiani LIU , Shan YE , Yongdong LI , Zaiying LU M D , . Role of nitric oxide in biological effects of vascular endothelial growth factor[J]. Front. Med., 2009, 3(3): 284-286.
[3] Geqing XIA, Chaoying WU. Expression of inducible nitric oxide synthase in trophoblasts and deciduas in early medical abortion[J]. Front Med Chin, 2009, 3(2): 216-219.
[4] WANG Lin, LIU Yalan, XU Jianbo, TIAN Yuan, WU Heshui. Protective effect of N-acetylcysteine against lipopolysaccharide injury in hepatocytes of neonatal mice[J]. Front. Med., 2008, 2(2): 182-185.
[5] TANG Zhongzhi, LI Junyao, YANG Jianhong. Relationship of endothelial nitric oxide synthase gene polymorphism with blood pressure, lipid profile and blood glucose level[J]. Front. Med., 2008, 2(2): 178-181.
[6] LI Xin, CHENG Chun, CHEN Mengling, GAO Shangfeng, ZHAO Jian, NIU Shuqiong, SHEN Aiguo. Developmental expression of CAPON and Dexras1 in spinal cord of rats[J]. Front. Med., 2008, 2(1): 75-81.
[7] WU Jun, LIN Jinchao, HE Zhaochu, OU Biru, GUO Haisen. Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate[J]. Front. Med., 2007, 1(4): 356-358.
[8] LI Yahui, DONG Shiyuan, YU Chao, JIANG Yu, LI Huaixing, SUN Shuhan. Influence and related mechanism of Retn gene expression on glucose uptake in 3T3-L1 cells[J]. Front. Med., 2007, 1(3): 269-273.
[9] LI Zhizhen, LI Fangping, YAN Li, LI Feng, LI Yan, CHENG Hua, FU Zuzhi. Study on the action of resistin-induced human umbilical vein endothelial cell dysfunction[J]. Front. Med., 2007, 1(2): 196-199.
Full text